Total Payments
$15,740
2024 Payments
$576.70
Companies
46
Transactions
753
Medicare Patients
1,936
Medicare Billing
$176,124
Payment Breakdown by Category
Food & Beverage$15,666 (99.5%)
Education$73.88 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,666 | 751 | 99.5% |
| Education | $73.88 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $3,069 | 143 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $2,674 | 130 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $2,038 | 65 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,782 | 77 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $884.05 | 55 | $0 (2024) |
| Mylan Specialty L.P. | $550.21 | 25 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $456.42 | 41 | $0 (2020) |
| Grifols USA, LLC | $455.66 | 23 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $443.81 | 18 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $432.98 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $576.70 | 25 | HARMONY BIOSCIENCES LLC ($141.89) |
| 2023 | $2,822 | 108 | AstraZeneca Pharmaceuticals LP ($576.17) |
| 2022 | $2,324 | 107 | AstraZeneca Pharmaceuticals LP ($668.18) |
| 2021 | $2,373 | 117 | JAZZ PHARMACEUTICALS INC. ($510.62) |
| 2020 | $1,298 | 79 | AstraZeneca Pharmaceuticals LP ($231.67) |
| 2019 | $2,557 | 129 | GlaxoSmithKline, LLC. ($497.20) |
| 2018 | $1,879 | 91 | GlaxoSmithKline, LLC. ($426.64) |
| 2017 | $1,909 | 97 | GlaxoSmithKline, LLC. ($848.30) |
All Payment Transactions
753 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/01/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $39.70 | General |
| Category: Cardiology | ||||||
| 04/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: IMMUNOLOGY | ||||||
| 04/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Respiratory | ||||||
| 04/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Immunology | ||||||
| 04/16/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $32.70 | General |
| Category: Narcoplepsy | ||||||
| 04/09/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 03/28/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: NEUROLOGY | ||||||
| 03/26/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $32.47 | General |
| Category: Narcoplepsy | ||||||
| 03/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/14/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $32.28 | General |
| Category: Narcoplepsy | ||||||
| 03/12/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 03/10/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $33.36 | General |
| Category: NEUROLOGY | ||||||
| 03/05/2024 | Itamar Medical Inc | WatchPATONE (Device) | Food and Beverage | Cash or cash equivalent | $24.97 | General |
| Category: Sleep Apnea testing | ||||||
| 03/01/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $15.06 | General |
| Category: HFCWO | ||||||
| 02/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $28.81 | General |
| Category: RESPIRATORY | ||||||
| 02/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Respiratory | ||||||
| 02/16/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 02/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: IMMUNOLOGY | ||||||
| 02/13/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 02/10/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: NEUROLOGY | ||||||
| 01/25/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $27.62 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 01/19/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $10.00 | General |
| Category: Narcoplepsy | ||||||
| 01/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug), STIOLTO RESPIMAT | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: RESPIRATORY | ||||||
| 01/08/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $34.44 | General |
| Category: Narcoplepsy | ||||||
| 01/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 372 | 471 | $49,760 | $33,617 |
| 2022 | 6 | 498 | 624 | $66,775 | $40,485 |
| 2021 | 8 | 547 | 675 | $102,923 | $51,359 |
| 2020 | 9 | 519 | 768 | $124,833 | $50,663 |
Total Patients
1,936
Total Services
2,538
Medicare Billing
$176,124
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 142 | 181 | $21,720 | $15,251 | 70.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 170 | 228 | $19,380 | $13,833 | 71.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $3,515 | $2,266 | 64.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $2,145 | $1,092 | 50.9% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 14 | 15 | $1,500 | $595.66 | 39.7% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 14 | 15 | $1,500 | $579.17 | 38.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 197 | 271 | $23,035 | $16,946 | 73.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 160 | 212 | $25,440 | $15,427 | 60.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 40 | 40 | $7,400 | $4,355 | 58.8% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 35 | 35 | $3,500 | $1,432 | 40.9% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 34 | 34 | $3,400 | $1,299 | 38.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 32 | 32 | $4,000 | $1,026 | 25.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 181 | 254 | $30,480 | $22,202 | 72.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 137 | 163 | $13,855 | $9,034 | 65.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 60 | 87 | $11,054 | $6,473 | 58.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 50 | 50 | $9,250 | $6,118 | 66.1% |
| 95811 | Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube | Facility | 2021 | 16 | 18 | $16,416 | $1,593 | 9.7% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Facility | 2021 | 17 | 17 | $11,512 | $1,539 | 13.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 12 | 12 | $2,406 | $1,197 | 49.7% |
| 94729 | Measurement of lung diffusing capacity | Office | 2021 | 25 | 25 | $2,500 | $1,193 | 47.7% |
| 94726 | Determination of lung volumes using plethysmography | Office | 2021 | 27 | 27 | $2,700 | $1,193 | 44.2% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 22 | 22 | $2,750 | $817.19 | 29.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 233 | 355 | $42,600 | $26,944 | 63.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 62 | 90 | $8,341 | $5,525 | 66.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 52 | 148 | $11,100 | $4,877 | 43.9% |
About Dr. Robert Reagle, DO
Dr. Robert Reagle, DO is a Pulmonary Disease healthcare provider based in Clarkston, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1619959509.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Reagle, DO has received a total of $15,740 in payments from pharmaceutical and medical device companies, with $576.70 received in 2024. These payments were reported across 753 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($15,666).
As a Medicare-enrolled provider, Reagle has provided services to 1,936 Medicare beneficiaries, totaling 2,538 services with total Medicare billing of $176,124. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Clarkston, MI
- Active Since 11/16/2005
- Last Updated 08/06/2019
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1619959509
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,043
- NUCALA (Biological) $1,036
- XYWAV (Drug) $965.59
- BREZTRI (Drug) $829.80
- STIOLTO RESPIMAT (Drug) $779.94
- OFEV (Drug) $706.04
- SYMBICORT (Drug) $676.82
- DUPIXENT (Biological) $615.42
- GLASSIA (Biological) $536.58
- Xyrem (Drug) $492.44
- Wakix (Drug) $477.05
- WAKIX (Drug) $407.00
- FASENRA (Biological) $396.93
- Yupelri (Drug) $376.73
- ACTHAR (Biological) $373.45
- Prolastin-C Liquid (Biological) $346.77
- SUNOSI (Drug) $295.63
- XYREM (Drug) $284.02
- INCRUSE (Drug) $212.01
- FASENRA (Drug) $205.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.